Subsequently, we stimulated peripheral blood neutrophils with these supernatants and determined neutrophil survival as well as the release of MMP9—both indicators of a pro-tumor neutrophil phenotype (Figure 6A). This evidence concerns the gene MMP9 and neoplasm.